Postnatal exposure to red blood cell transfusion (RBCT) in premature infants is an important risk factor for Retinopathy of Prematurity (ROP) progression. We hypothesized that higher number and earlier timing of RBCT are associated with worse ROP severity and result in laser treatment at an earlier postmenstrual age (PMA) in very low birth weight (≤1500 g, VLBW) infants.
METHODS:
A retrospective medical record review of 631 VLBW infants over a 5-year period was performed. Demographic features and potential clinical risk factors including number of RBCT, ROP severity, and progression to laser treatment were collected to evaluate predictors of severe ROP. ANCOVA, pairwise post-hoc analyses, and multivariate regression were used to determine associations between frequency and timing of RBCT and ROP severity.
RESULTS:
Of the 456 eligible infants, 61 developed severe ROP (13%). There was significant correlation between number of RBCTs and ROP severity, adjusted for gestational age and birthweight (Adjusted R2 = 0.53; p < 0.001). Compared to infants with No/Mild and Type 2 ROP, infants with Type 1 ROP received more RBCTs, with higher number of RBCTs per week during the first month of life (mean RBCT in ROP No/Mild 5.7±0.4 vs Type 2 16.3±1.8 vs Type 1 22.4±1.5, p = 0.042). Laser-treated infants received a higher number of RBCTs than non-treated infants (mean RBCT 22.3 vs. 6.5, p < 0.001) but no correlation was observed between number of RBCTs and PMA at time of laser treatment.
CONCLUSION:
Higher number of RBCTs in early postnatal life of VLBW infants was associated with more severe ROP.
GilbertC. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Human Development. 2008;84(2):77–82.
2.
The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991–9.
3.
FiersonWM, Ophthalmology AAoPSo. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018;142(6).
4.
IversonDA, TreseMT, OrgelIK, WilliamsGA. Laser photocoagulation for threshold retinopathy of prematurity. Arch Ophthalmol. 1991;109(10):1342–3.
5.
HunterDG, RepkaMX. Diode laser photocoagulation for threshold retinopathy of prematurity: a randomized study. Ophthalmology. 1993;100(2):238–44.
6.
WangYC, ChanOW, ChiangMC, YangPH, ChuSM, HsuJF, et al. Red blood cell transfusion and clinical outcomes in extremely low birth weight preterm infants. Pediatr Neonatol. 2017;58(3):216–22.
7.
LustC, VesoulisZ, JackupsR, LiaoS, RaoR, MathurAM. Early red cell transfusion is associated with development of severe retinopathy of prematurity. J Perinatol. 2019;39(3):393–400.
8.
WhyteRK, JefferiesAL, SocietyCP, Fetus, Committee N. Red blood cell transfusion in newborn infants. Paediatri Child Health. 2014;19(4):213–7.
9.
ClarkC, GibbsJA, ManielloR, OuterbridgeEW, ArandaJV. Blood transfusion: A possible risk factor in retrolental fibroplasia. Acta Paediatr Scand. 1981;70(4):537–9.
10.
HesseL, EberlW, SchlaudM, PoetsCF. Blood transfusion. Iron load and retinopathy of prematurity. Eur J Pediatr. 1997;156(6):465–70.
11.
FranzAR, EngelC, BasslerD, RüdigerM, ThomeUH, MaierRF, et al.. Effects of liberal vs restrictive transfusion thresholds on survival and neurocognitive outcomes in extremely low-birth-weight infants: The ettno randomized clinical trial. JAMA. 2020;324(6):560–70.
12.
BrooksSE, MarcusDM, GillisD, PirieE, JohnsonMH, BhatiaJ. The effect of blood transfusion protocol on retinopathy of prematurity: A prospective, randomized study. Pediatrics. 1999;104(3 Pt 1):514–8.
13.
KirpalaniH, BellEF, HintzSR, TanS, SchmidtB, ChaudharyAS, et al.. Higher or lower hemoglobin transfusion thresholds for preterm infants. NEJM. 2020;383(27):2639–51.
14.
KneeD, KnoopS, DavisAT, RawsonB, DiCarloA, OliveroR. Outcomes after implementing restrictive blood transfusion criteria in extremely premature infants. J Perinatol. 2019;39(8):1089–97.
15.
KeirA, PalS, TrivellaM, LiebermanL, CallumJ, ShehataN, et al.. Adverse effects of red blood cell transfusions in neonates: A systematic review and meta-analysis. Transfusion. 2016;56(11):2773–80.
16.
HowarthC, BanerjeeJ, AladangadyN. Red blood cell transfusion in preterm infants: current evidence and controversies. Neonatology. 2018;114(1):7–16.
17.
NugudAA, NugudS, NugudA, NugudAA, KathamuthuR, JalalM. Perinatal risk factors for development of retinopathy of prematurity in a tertiary neonatal intensive care unit. J Taibah Univer Med Sci. 2019;14(3):306–11.
18.
SlidsborgC, JensenA, FormanJL, RasmussenS, BangsgaardR, FledeliusHC, et al.. Neonatal risk factors for treatment-demanding retinopathy of prematurity: A Danish national study. Ophthalmology. 2016;123(4):796–803.
19.
KirpalaniH, WhyteR. The tangled duo of anaemia and transfusion travel together, that is the problem. Acta Paediatrica. 2018;107(5):730–1.
20.
UedaK, KimHJ, ZhaoJ, SongY, DunaiefJL, SparrowJR. Iron promotes oxidative cell death caused by bisretinoids of retina. PNAS. 2018;115(19):4963–8.
21.
CollardKJ. Transfusion related morbidity in premature babies: Possible mechanisms and implications for practice. World J Clin Pediatr. 2014;3(3):19–29.
22.
TriulziDJ, YazerMH. Clinical studies of the effect of blood storage on patient outcomes. Transfus Aphere Sci. 2010;43(1):95–106.
23.
García-RoaM, del Carmen Vicente-AyusoM, BobesAM, PedrazaAC, González-FernándezA, MartínMP, et al.. Red blood cell storage time and transfusion: Current practice, concerns and future perspectives. Blood Transfus. 2017;15(3):222.
24.
OzsurekciY, AykacK. Oxidative stress related diseases in newborns. Oxid Med Cell Longev. 2016;2016.
25.
Ophthalmology AAoPSo. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013;131(1):189–95.
26.
Prematurity ICftCoRo. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005;123(7):991.
27.
Group ETfRoPC. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1684.
28.
CookeR, ClarkD, Hickey-DwyerM, WeindlingA. The apparent role of blood transfusions in the development of retinopathy of prematurity. Eur J Pediatri. 1993;152(10):833–6.
29.
DaniC, RealiM, BertiniG, MartelliE, PezzatiM, RubaltelliF. The role of blood transfusions and iron intake on retinopathy of prematurity. Early Hum Dev. 2001;62(1):57–63.
30.
KeirA, AzizK, McMillanD, MonterrosaL, OjahC, LeeS, et al. Red blood cell transfusions at 21 days of age or older in previously transfusion-naive very preterm infants: association with neonatal outcomes. Am J Perinatol. 2015;32(12):1139–44.
31.
RomagnoliC, ZeccaE, GalliniF, GirlandoP, ZuppaAA. Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?Eur J Pediatri. 2000;159(8):627.
32.
InderTE, ClemettRS, AustinNC, GrahamP, DarlowBA. High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity. J Pediatr. 1997;131(4):541–4.
33.
VamvakasEC, BlajchmanMA. Transfusion-related immunomodulation (TRIM): An update. Blood Rev. 2007;21(6):327–438.
34.
HiranoK, MorinobuT, KimH, HiroiM, BanR, OgawaS, et al. Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2001;84(3):F188–193.
35.
StutchfieldCJ, JainA, OddD, WilliamsC, MarkhamR. Foetal haemoglobin, blood transfusion, and retinopathy of prematurity in very preterm infants: A pilot prospective cohort study. Eye (Lond). 2017;31(10):1451–1415.
36.
OhlsRK, ChristensenRD. Recombinant erythropoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatri. 1991;119(5):781–8.
37.
AherSM, OhlssonA. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database of Syst Rev. 2020(2).
38.
HwangJH, LeeEH, KimEA-R. Retinopathy of prematurity among very-low-birth-weight infants in Korea: incidence, treatment, and risk factors. J Korean Med Sci. 2015;30(Suppl 1):S88–S94.
39.
SundararajanS, RabeH. Prevention of iron-deficiency anemia in infants and toddlers. Pediatric Res. 2020:1-12.
40.
Practice CoO. Committee opinion No. 684: Delayed umbilical cord clamping after birth. Obstetrics and Gynecology. 2017;129(1):e5.
41.
CarrollPD, ChristensenRD. New and underutilized uses of umbilical cord blood in neonatal care. Matern Health Neonatol Perinatol. 2015;1(1):16.
42.
LinJC, StraussRG, KulhavyJC, JohnsonKJ, ZimmermanMB, CressGA, et al. Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics. 2000;106(2):e19–e.
